Acta Med. 2007, 50: 17-21
https://doi.org/10.14712/18059694.2017.54
Inflammation and Genes
References
1. VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthr Res Ther 2005; 7: R196–207.
<https://doi.org/10.1186/ar1472>
<PubMed>
2. J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock 2005; 24:300–12.
<https://doi.org/10.1097/01.shk.0000180621.52058.e1>
3. Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol. 2006 Sep 21; [Epub ahead of print].
4. N, Aguirre JE, Reinecker HC, et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–kB activation in muramyl dipeptide recognition. J Cell Biol 2005; 170:21–6.
<https://doi.org/10.1083/jcb.200502153>
<PubMed>
5. C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116:536–47.
<https://doi.org/10.1172/JCI26679>
<PubMed>
6. S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 2006; 55:342–7.
<https://doi.org/10.1136/gut.2005.065557>
<PubMed>
7. L, Johnson C, Burslem F, Martin P. Wound healing and inflammation genes revealed by array analysis of ‘macrophageless’ PU.1 null mice. Genome Biology 2004, 6:R5.
<https://doi.org/10.1186/gb-2004-6-1-r5>
<PubMed>
8. JE, Jowett, JBM, Elliott KS et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 2005; 37:1234–41.
<https://doi.org/10.1038/ng1655>
9. Daneholt B. Advanced Information. RNA interference. The Nobel Prize in Physiol or Med 2006. http://nobelprize.org/nobel_prizes/medicine/laureates/ 2006/adv.html.
10. RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461–3.
<https://doi.org/10.1126/science.1135245>
<PubMed>
11. RL, Thiberge M, Kansau I, et al. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A. 1995; 92:6499–503.
<https://doi.org/10.1073/pnas.92.14.6499>
<PubMed>
12. JL, Perry GH, Feuk L, et al. Copy number variation: new insights in genome diversity. Genome Res. 2006; 16:949–61.
<https://doi.org/10.1101/gr.3677206>
13. JS. Are prostaglandins proinflammatory, antiinflammatory, both or neither? J Rheumatol 1991; 18 (Supp28):26–9.
14. SK, Fitzgerald JF, Kondratyuk T, Hogenesch H. Cytokine expression in normal and inflamed esophageal mucosa: A study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006; 42:22–6.
<https://doi.org/10.1097/01.mpg.0000188740.38757.d2>
15. A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology 2006; 45:365–8.
<https://doi.org/10.1093/rheumatology/kel005>
16. GL, Lapadat R. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases. Science 2002; 298:1911–12.
<https://doi.org/10.1126/science.1072682>
17. E, Bazargani A, Masoudian M, Lankarani K, Taghavi A-R, Saberifiroozi M. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 2006; 12:5205–10.
18. RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science 2005; 308:362–4.
<https://doi.org/10.1126/science.1109557>
<PubMed>
19. R, Paigen B. From QTL to gene: the harvest begins. Nat Genet 2002; 31:235–6.
<https://doi.org/10.1038/ng0702-235>
20. Y-F, Wu M-S, Chang CC, et al. Comparative immunoproteomics of identification and characterization virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics 2006; 5:1484–96.
<https://doi.org/10.1074/mcp.M600111-MCP200>
21. MP, Camandola S. NF-kB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107:247–54.
<https://doi.org/10.1172/JCI11916>
<PubMed>
22. PL, McGeer EG. Inflammation and the degenerative diseases of aging. Annals NYAS 2004; 1035:104–6.
23. PL, McGeer EG. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001; 58:1790–2.
<https://doi.org/10.1001/archneur.58.11.1790>
24. NK, Kanga U. Molecular diversity of the HLA-B27 gene and its association with disease. J Modern Rheumatol 2001; 11:275–285.
<https://doi.org/10.3109/s10165-001-8056-0>
25. T, Covacci A, Kist M, Pahl HL. Helicobacter pylori activates MAP kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 2006; 275:16064–72.
<https://doi.org/10.1074/jbc.M000959200>
26. JP, Lupa MM, Spieker MS. NF-kB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation. BMC Immunology 2004; 5: 1–11.
<https://doi.org/10.1186/1471-2172-5-10>
<PubMed>
27. RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316–21.
<https://doi.org/10.1164/ajrccm.163.2.2007102>
28. PI, Sivaraj RR. Anti-TNF- therapy for uveitis: Behcet and beyond. Eye 2005; 19:831–3.
<https://doi.org/10.1038/sj.eye.6701792>
29. C. Points of control in inflammation. Nature 2002; 420:846–52.
<https://doi.org/10.1038/nature01320>
30. A, Beckmann L, Deeg E, Becker N. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006; 7:615–24.
<https://doi.org/10.1038/sj.gene.6364337>
31. Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411:603–6.
<https://doi.org/10.1038/35079114>
32. S, Buckner JH, Concannon P. A Haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 2006; 55:2883–89.
<https://doi.org/10.2337/db06-0225>
33. AS. Genetics of inflammatory bowel disease. The candidate gene approach: susceptibility versus disease heterogeneity. Dig Dis 1998; 16:356–63.
<https://doi.org/10.1159/000016892>
34. K, Kedersha N, Shen L, Blackshear PJ, Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor, cyclooxygenase 2, and inflammatory arthritis. Proc Natl Acad Sci USA 2004; 101:2011–16.
<https://doi.org/10.1073/pnas.0400148101>
<PubMed>
35. JA, Steinert PM. The structure of the gene for mouse filaggrin and a comparison of the repeating units. J Biol Chem 1990; 265:1862–5.
36. J, Dean J, Clark A. Control of the expression of inflammatory response genes. Biochem Soc Symp 2003; 70:95–106.
<https://doi.org/10.1042/bss0700095>
37. F, Convertino R, Molino N, et al. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity 2003; 36:71–7.
<https://doi.org/10.1080/0891693031000079275>
38. FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris Nature Genetics 2006; 38:337–42.
<https://doi.org/10.1038/ng1743>
39. M, Duvefelt K, Diez M, et al. Genetically determined susceptibility to neurodegeneration is associated with increased expression of inflammatory genes. Neurobiol Dis 2006; 24:67–88.
<https://doi.org/10.1016/j.nbd.2006.05.016>
40. PP, Firestein GS. NF-kB: a key role in inflammatory diseases. J Clin Invest 2001; 107:7–11.
<https://doi.org/10.1172/JCI11830>
<PubMed>
41. KJ, Warren HS. Human Genetics: An inflammatory issue. Nature 2004; 429:35–7.
<https://doi.org/10.1038/429035a>
42. KJ. The inflammatory reflex. Nature 2002; 420:853–85.
<https://doi.org/10.1038/nature01321>
43. NK, Miserocchi E, Foster CS, et al. Ocular concerns in juvenile rheumatoid arthritis. Immunol Inflamm. Ocul Immunol Inflamm. 2005; 13:205–12.
44. J, Stange EF. A new look at Crohn’s disease: breakdown of the mucosal antibacterial defense. Ann NY Acad Sci 2006; 1072:321–31.
<https://doi.org/10.1196/annals.1326.030>
45. CA, Ravasi T, Hume DA. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol 2005; 78:9–13.
<https://doi.org/10.1189/jlb.1204710>
46. Y, Deng CS, Peng JZ, Wong BC-Y, Lam SK, Xia HH-X. Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol 2003; 56:19–24.
<https://doi.org/10.1136/mp.56.1.19>
<PubMed>
47. S, Kari E, Branham KEH, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77:149–53.
<https://doi.org/10.1086/431426>
<PubMed>
48. J. Dampening the silencing effect of RNA interference in mammals. Biochem J 2005; 390:675–9.
<https://doi.org/10.1042/BJ20050390>
<PubMed>
49. W, She J-X. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type I diabetes. Diabetes 2005; 54:906–8.
<https://doi.org/10.2337/diabetes.54.3.906>
